Search

everythinglearnresearchcommunity

for

Search:↓

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

The trichoscopy-assisted hair pull test is useful for diagnosing different types of hair loss.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The excimer lamp is a safe and effective treatment for severe alopecia areata.

An elderly man's hair grew back after a treatment that transferred healthy gut bacteria.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

A boy's hair, nails, and skin improved after 6 months of steroid treatment.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

Switching to twice-weekly betamethasone led to full hair regrowth in 3 months without side effects.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.